Similar articles

• [Suboptimal results of Optimaal: treatment with ACE inhibitors remains the preferred therapy in patients with left ventricular dysfunction after acute myocardial infarct]].

  Danchin N. Danchin N. Herz. 2002 Dec;27(8):(18). Herz. 2002. PMID: 12608391 German. No abstract available.
• The OPTIMAAL study, not so optimal: the lessons of LIFE, RENAAL and IDNT.

  Lapointe N, Pourdjabbar A, Rouleau JL. Lapointe N, et al. Can J Cardiol. 2003 Aug;19(9):994-6. Can J Cardiol. 2003. PMID: 12915925 No abstract available.
• Left ventricular remodeling after acute myocardial infarction.

  Pfeffer MA. Pfeffer MA. Annu Rev Med. 1995;46:455-66. doi: 10.1146/annurev.med.46.1.455. Annu Rev Med. 1995. PMID: 7598478 Review.
• Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.

  Suşan M, Petrescu L, Riviş AI, Suşan RM, Burghină D, Dan R, Cozma D, Drăgulescu SI. Suşan M, et al. Rom J Intern Med. 2005;43(3-4):187-98. Rom J Intern Med. 2005. PMID: 16812979 Clinical Trial.
• Angiotensin-converting enzyme inhibitor and/or angiotensin receptor antagonist for the postmyocardial infarction patient.

  Scott RL. Scott RL. Cardiol Clin. 2008 Feb;26(1):73-7, vii. doi: 10.1016/j.ccl.2007.10.004. Cardiol Clin. 2008. PMID: 18312907 Review.